Geminin Overexpression Promotes Imatinib Sensitive Breast Cancer: A Novel Treatment Approach for Aggressive Breast Cancers, Including a Subset of Triple Negative

• Zannel Blanchard,

  Affiliations Cancer Institute, University of Mississippi Medical Center, Jackson, Mississippi, United States of America, Department of Biochemistry, University of Mississippi Medical Center, Jackson, Mississippi, United States of America

  ⨯
• Nicole Mullins,

  Affiliation Cancer Institute, University of Mississippi Medical Center, Jackson, Mississippi, United States of America

  ⨯
• Pavani Ellipeddi,

  Affiliation Cancer Institute, University of Mississippi Medical Center, Jackson, Mississippi, United States of America

  ⨯
• Janice M. Lage,

  Affiliation Department of Pathology, University of Mississippi Medical Center, Jackson, Mississippi, United States of America

  ⨯
• Shawn McKinney,

  Affiliation Department of Surgery, University of Mississippi Medical Center, Jackson, Mississippi, United States of America

  ⨯
• Rana El-Etriby,

  Affiliation Cancer Institute, University of Mississippi Medical Center, Jackson, Mississippi, United States of America

  ⨯
• Xu Zhang,

  Affiliation Center of Biostatistics and Bioinformatics, University of Mississippi Medical Center, Jackson, Mississippi, United States of America

  ⨯
• Raphael Isokpehi,

  Affiliation Center for Bioinformatics & Computational Biology, Department of Biology, Jackson State University, Jackson, Mississippi, United States of America

  ⨯
• Brenda Hernandez,

  Affiliation Cancer Research Center of Hawaii, University of Hawaii, Honolulu, Hawaii, United States of America

  ⨯
• Wael M. ElShamy

  * E-mail: welshamy@umc.edu

  Affiliations Cancer Institute, University of Mississippi Medical Center, Jackson, Mississippi, United States of America, Department of Biochemistry, University of Mississippi Medical Center, Jackson, Mississippi, United States of America

  ⨯